NYSE:IVC - Invacare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $14.00
  • Forecasted Upside: 53.85 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$9.10
▲ +0.1 (1.11%)
1 month | 3 months | 12 months
Get New Invacare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IVC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IVC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$14.00
▲ +53.85% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Invacare in the last 3 months. The average price target is $14.00, with a high forecast of $17.00 and a low forecast of $11.00. The average price target represents a 53.85% upside from the last price of $9.10.
Buy
The current consensus among 2 investment analysts is to buy stock in Invacare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/12/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/11/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/10/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/8/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/6/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/3/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/5/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/14/2020Needham & Company LLCReiterated RatingBuyHigh
i
Rating by Michael Matson at Needham & Company LLC
6/1/2020Needham & Company LLCReiterated RatingBuy$17.00Medium
i
Rating by Michael Matson at Needham & Company LLC
5/7/2020Needham & Company LLCReiterated RatingBuy$17.00High
i
Rating by Michael Matson at Needham & Company LLC
4/14/2020Needham & Company LLCReiterated RatingBuy$17.00High
i
Rating by Michael Matson at Needham & Company LLC
3/23/2020StephensLower Price TargetOverweight$17.00 ➝ $11.00High
i
3/9/2020Needham & Company LLCReiterated RatingBuy$17.00Low
i
Rating by Michael Matson at Needham & Company LLC
2/10/2020Needham & Company LLCReiterated RatingBuy$17.00Medium
i
11/6/2019Needham & Company LLCReiterated RatingBuy$15.00High
i
10/10/2019Needham & Company LLCReiterated RatingBuy$15.00Low
i
4/9/2019Needham & Company LLCReiterated RatingBuy$15.00Low
i
2/14/2019Needham & Company LLCReiterated RatingBuy$15.00High
i
1/24/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$15.00High
i
5/9/2018KeyCorpLower Price TargetOverweight ➝ Overweight$24.00 ➝ $23.00Low
i
5/2/2018UBS GroupUpgradeSell ➝ NeutralLow
i
3/15/2018KeyCorpReiterated RatingBuyHigh
i
2/9/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$20.00 ➝ $21.00Medium
i
12/21/2017KeyCorpReiterated RatingBuy$20.00Low
i
11/10/2017KeyCorpReiterated RatingBuy$18.00N/A
i
9/26/2017KeyCorpReiterated RatingOverweight$17.00Medium
i
6/12/2017SidotiReiterated RatingNeutral$14.00 ➝ $12.00Medium
i
4/28/2017StephensUpgradeEqual Weight ➝ OverweightHigh
i
4/4/2017StephensReiterated RatingEqual WeightHigh
i
10/6/2016KeyCorpSet Price TargetBuy$17.00N/A
i
Rating by Matthew Mishan at KeyCorp
(Data available from 3/5/2016 forward)
Invacare logo
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Read More

Today's Range

Now: $9.10
$8.60
$9.29

50 Day Range

MA: $9.59
$8.58
$10.59

52 Week Range

Now: $9.10
$3.90
$10.94

Volume

176,585 shs

Average Volume

209,648 shs

Market Capitalization

$313.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Frequently Asked Questions

What sell-side analysts currently cover shares of Invacare?

The following sell-side analysts have issued stock ratings on Invacare in the last twelve months: Needham & Company LLC, Stephens, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for IVC.

What is the current price target for Invacare?

2 Wall Street analysts have set twelve-month price targets for Invacare in the last year. Their average twelve-month price target is $14.00, suggesting a possible upside of 58.6%. Needham & Company LLC has the highest price target set, predicting IVC will reach $17.00 in the next twelve months. Stephens has the lowest price target set, forecasting a price of $11.00 for Invacare in the next year.
View the latest price targets for IVC.

What is the current consensus analyst rating for Invacare?

Invacare currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IVC will outperform the market and that investors should add to their positions of Invacare.
View the latest ratings for IVC.

What other companies compete with Invacare?

How do I contact Invacare's investor relations team?

Invacare's physical mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider's listed phone number is 440-329-6000 and its investor relations email address is [email protected] The official website for Invacare is www.invacare.com.